{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-192025-04-192025-04-202025-04-202025-04-212025-04-212025-04-222025-04-222025-04-232025-04-232025-04-242025-04-2431773232133213103404030302020101000
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-192025-04-192025-04-202025-04-202025-04-212025-04-212025-04-222025-04-222025-04-232025-04-232025-04-242025-04-243723710642220223404030302020101000
Download SVG
Download PNG
Download CSV

ecb meeting highlights potential interest rate cut and economic data focus

The ECB meeting today is pivotal, with expectations of a 25 basis point interest rate cut, following a significant drop in eurozone inflation. Investors are also focused on US retail sales and jobless claims data, alongside key economic indicators from China. The EUR/USD trading range of 1.08 to 1.12 dollars remains crucial, with potential implications for market movements.
10:59 17.10.2024

UBS reduces DocMorris price target to 25 francs maintains sell rating

UBS has reduced its price target for DocMorris from 27 to 25 francs, maintaining a "Sell" rating. Analyst Sebastian Vogel noted that the online pharmacy's recent statements indicate a weaker growth outlook for prescription drugs in the German market in the near term.
10:52 17.10.2024

UBS downgrades DocMorris price target amid concerns over growth in Germany

UBS has downgraded its price target for DocMorris from 27 to 25 francs, maintaining a "Sell" rating. Analyst Sebastian Vogel noted that the online pharmacy's recent statements indicate a weaker growth outlook for prescription drugs in the German market in the near term.
10:52 17.10.2024

groundbreaking digital health innovations showcased at gitex global in dubai

GITEX GLOBAL's DIGI_HEALTH 5.0 in Dubai showcased transformative digital health innovations, including AI-driven solutions and smart contact lenses, highlighting the UAE's commitment to advancing its digital health ecosystem. Industry leaders discussed AI's role in enhancing patient care, with significant advancements in robotics, genomics, and remote monitoring technologies. The event also announced plans for a future expo-summit in Thailand, aimed at addressing the growing demands of the digital health industry in Asia.

UBS maintains neutral rating for Pernod Ricard amid sales decline

UBS has maintained a "Neutral" rating for Pernod Ricard, setting a target price of 138 euros, following disappointing sales figures that fell more than anticipated, particularly in Asia. Analyst Sanjeet Aujla noted that expectations for the spirits manufacturer have declined recently.
09:29 17.10.2024

ubs cuts puma se target price to 43.50 euros maintains neutral rating

UBS has reduced its target price for Puma SE from 48.50 to 43.50 euros, maintaining a "Neutral" rating. Analyst Robert Krankowski noted that Puma is currently facing challenges, with profitability expectations for 2025 becoming increasingly difficult to meet.
09:27 17.10.2024

pharmaceutical company secures law change amid rising health insurance costs

Germany's pharmaceutical landscape faces challenges as Eli Lilly begins construction of a new plant in Rhineland-Palatinate, reportedly linked to a law change allowing confidential pricing for medicines. This shift, criticized for potentially raising health insurance costs, has sparked concerns among health officials about increased expenditures for the public. Eli Lilly denies any direct connection between its investment and the legislative change.

UBS lowers Puma price target amid profitability concerns and maintains neutral rating

UBS has reduced its price target for Puma SE from €48.50 to €43.50 while maintaining a "Neutral" rating. Analyst Robert Krankowski noted that Puma is currently facing challenges in achieving its profitability targets for 2025, as recent favorable conditions have shifted to headwinds.
08:40 17.10.2024

ubs downgrades a p moller maersk to neutral amid market shifts

UBS has downgraded A.P. Møller-Maersk to neutral from buy. The company, a leader in maritime transportation, operates a fleet of over 707 vessels and offers port and logistics services. Its net sales are geographically diverse, with significant contributions from the United States (22.4%) and other regions.
08:38 17.10.2024

ubs downgrades a p moller maersk to neutral amid market shifts

UBS has downgraded A.P. Möller-Maersk to neutral from buy. The company, a leader in maritime transportation, operates over 707 vessels and offers port and logistics services. Its net sales are primarily generated from the United States (22.4%), with other significant contributions from various countries.
08:38 17.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.